CME vs. REMIX

Last updated Jun 9, 2026

CME (CME Group Inc.) is a stock, while REMIX (Standpoint Multi-Asset Fund Investor Class) is Macro Trading fund managed by Standpoint Asset Management. Over the past 5 years, CME returned 7.50%/yr vs 8.63%/yr for REMIX. At a 0.20 correlation, their price movements are largely independent.

Performance

CME vs. REMIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CME Group Inc. (CME) and Standpoint Multi-Asset Fund Investor Class (REMIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CME achieves a -5.50% return, which is significantly lower than REMIX's 13.77% return.

CME

• 1D: -2.09%
• 1M: -10.39%
• YTD: -5.50%
• 6M: -4.13%
• 1Y: -4.58%
• 3Y*: 15.54%
• 5Y*: 7.50%
• 10Y*: 14.50%

REMIX

• 1D: -2.27%
• 1M: -1.70%
• YTD: 13.77%
• 6M: 15.58%
• 1Y: 27.65%
• 3Y*: 10.77%
• 5Y*: 8.63%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CME vs. REMIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
CME CME Group Inc.	-5.50%	19.83%	15.41%	31.32%	-22.89%	29.47%	-6.87%
REMIX Standpoint Multi-Asset Fund Investor Class	13.77%	3.85%	12.92%	5.53%	3.44%	19.81%	16.06%

Correlation

The correlation between CME and REMIX is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.04
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (All Time) Calculated using the full available price history since Jan 3, 2020	0.20

The correlation between CME and REMIX shifts across timeframes, from -0.01 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Return for Risk

CME vs. REMIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CME

CME Risk / Return Rank: 30
CME Sharpe Ratio Rank: 33
CME Sortino Ratio Rank: 27
CME Omega Ratio Rank: 27
CME Calmar Ratio Rank: 35
CME Martin Ratio Rank: 28

REMIX

REMIX Risk / Return Rank: 70
REMIX Sharpe Ratio Rank: 60
REMIX Sortino Ratio Rank: 51
REMIX Omega Ratio Rank: 54
REMIX Calmar Ratio Rank: 96
REMIX Martin Ratio Rank: 92

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CME vs. REMIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CME Group Inc. (CME) and Standpoint Multi-Asset Fund Investor Class (REMIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CME	REMIX	Difference
Sharpe ratio: Return per unit of total volatility	-0.23	2.16	-2.39
Sortino ratio: Return per unit of downside risk	-0.17	2.84	-3.01
Omega ratio: Gain probability vs. loss probability	0.98	1.38	-0.40
Calmar ratio: Return relative to maximum drawdown	-0.21	5.83	-6.05
Martin ratio: Return relative to average drawdown	-0.72	18.59	-19.31
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CME vs. REMIX - Sharpe Ratio Comparison

The current CME Sharpe Ratio is -0.23, which is lower than the REMIX Sharpe Ratio of 2.16. The chart below compares the historical Sharpe Ratios of CME and REMIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CME	REMIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.23	2.16	-2.39
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.38	0.74	-0.36
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.61	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.59	0.99	-0.40

Drawdowns

CME vs. REMIX - Drawdown Comparison

The maximum CME drawdown since its inception was -77.50%, which is greater than REMIX's maximum drawdown of -17.89%. Use the drawdown chart below to compare losses from any high point for CME and REMIX.

Drawdown Indicators

	CME	REMIX	Difference
Max Drawdown Largest peak-to-trough decline	-77.50%	-17.89%	-59.61%
Max Drawdown (1Y) Largest decline over 1 year	-21.42%	-4.78%	-16.64%
Max Drawdown (3Y) Largest decline over 3 years	-21.42%	-17.89%	-3.53%
Max Drawdown (5Y) Largest decline over 5 years	-31.74%	-17.89%	-13.85%
Max Drawdown (10Y) Largest decline over 10 years	-37.36%	—	—
Current Drawdown Current decline from peak	-20.95%	-3.90%	-17.05%
Average Drawdown Average peak-to-trough decline	-20.69%	-3.29%	-17.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.35%	1.50%	+4.85%

Volatility

CME vs. REMIX - Volatility Comparison

CME Group Inc. (CME) has a higher volatility of 10.21% compared to Standpoint Multi-Asset Fund Investor Class (REMIX) at 3.71%. This indicates that CME's price experiences larger fluctuations and is considered to be riskier than REMIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CME	REMIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.21%	3.71%	+6.50%
Volatility (6M) Calculated over the trailing 6-month period	16.89%	9.77%	+7.12%
Volatility (1Y) Calculated over the trailing 1-year period	20.38%	12.90%	+7.48%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.06%	11.71%	+8.35%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.89%	11.79%	+12.10%

Dividends

CME vs. REMIX - Dividend Comparison

CME's dividend yield for the trailing twelve months is around 4.44%, more than REMIX's 0.41% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CME CME Group Inc.	4.44%	1.83%	4.48%	4.58%	5.05%	3.00%	3.24%	2.74%	2.42%	4.20%	4.90%	5.41%
REMIX Standpoint Multi-Asset Fund Investor Class	0.41%	0.47%	5.52%	3.46%	2.48%	6.04%	1.09%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CME and REMIX in my portfolio?

CME and REMIX have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CME or REMIX?

CME has higher volatility (10.21%) compared to REMIX (3.71%). In terms of maximum drawdown, CME dropped -77.50% vs REMIX's -17.89%.

Which has better risk-adjusted returns?

REMIX currently has the higher Sharpe Ratio (2.16 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.